URGN

UroGen Pharma Ltd. [URGN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

URGN Stock Summary

Top 10 Correlated ETFs

URGN


Top 10 Correlated Stocks

URGN


In the News

URGN Financial details

Company Rating
-
Market Cap
515.24M
Income
-102.24M
Revenue
82.71M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
198
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-4.52
Forward P/E
-
PEG
2.04
P/S
5.82
P/B
-11.24
P/C
-
P/FCF
-5.28
Quick Ratio
6.21
Current Ratio
7.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.73
EPS next Y
-
EPS next Q
-
EPS this Y
-25.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.24%
Revenue last 5Y
440.08%
Revenue Q/Q
12.84%
EPS Q/Q
5.88%
-
-
-
-
SMA20
10%
SMA50
10%
SMA100
-8.33%
Inst Own
-
Inst Trans
-
ROA
-54%
ROE
108%
ROC
-0.42%
Gross Margin
88%
Oper. Margin
-92%
Profit Margin
-135%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.69-24.13
52W High
-55.79%
52W Low
+32.63%
RSI
45
Rel Volume
1.27
Avg Volume
354.62K
Volume
450.64K
Perf Week
-6.93%
Perf Month
-0.93%
Perf Quarter
-10.77%
Perf Half Y
-17.75%
-
-
-
-
Beta
1.084
-
-
Volatility
0.28%, 0.88%
Prev Close
-4.07%
Price
10.61
Change
-2.48%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap